Steroidogenic factor 1 (SF-1)

Steroidogenic factor 1 (SF-1), encoded by the NR5A1 gene, is a nuclear receptor and transcription factor that is essential for mammalian sexual differentiation, adrenal gland development, and the regulation of steroid hormone biosynthesis[1][2][3][4][5][6]. This orphan nuclear receptor binds DNA as a monomer, recognizing specific regulatory elements in the promoters of steroidogenic genes, and orchestrates the expression of key enzymes needed for cortisol, aldosterone, and sex steroid synthesis[1][2]. SF-1 is a master regulator of the hypothalamic-pituitary-gonadal and adrenal axes, and its dosage is critical for normal endocrine function[8]. Mutations in the NR5A1 gene are implicated in a variety of human disorders including gonadal dysgenesis (such as Swyer syndrome), adrenal insufficiency, and certain endocrine tumors[5]. SF-1 lacks an identified high-affinity endogenous ligand, although recent studies indicate that phospholipids may partially fulfill this regulatory function[2]. Although no approved drugs currently target SF-1 directly, it is a focus of active research as a potential therapeutic and diagnostic target in reproductive and adrenal diseases, as well as adrenal carcinomas[2][8].

Other names

SF-1NR5A1Ad4BP (Adrenal 4 binding protein)FTZF1 (Fushi tarazu factor 1 homolog)Nuclear receptor subfamily 5 group A member 1

Modulation of transcriptional activity through ligand (phospholipid)-dependent or independent mechanisms - Regulation of steroidogenic gene promoters in adrenal and gonadal tissues[2][3]. - Currently no approved drugs with established, clinically relevant mechanism—investigational molecules affect DNA binding or coactivator recruitment.